As we all know firsthand, NWBio has been notoriously slow to meet timelines. In part, because they don’t have a lot of staff. In this case however, I think they are singularly focused on reviewing & analyzing TLD & releasing it to the public.
But, I do believe the US clinical trial site will be updated soon, either just before or just after TLD release. BTW, I forgot to add 2 more facts:
(7) NWBio said they would not lock or unblind the data until they got buy-in from all 4 regulatory authorities, then on 10/5/2020, NWBio issued a PR saying they had locked the data.
(8) Then, 3 days later on 10/8/2020, the EU updated the endpoints in the clinical trial registry for the UK.
(9) A few days later, the clinical trial registry for Germany was updated with the new endpoints.
Everything fits together like a glove.
Market Data 
Markets 
